These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Sequential analysis of kidney stone formation in the Aprt knockout mouse. Evan AP; Bledsoe SB; Connors BA; Deng L; Liang L; Shao C; Fineberg NS; Grynpas MD; Stambrook PJ; Youzhi S; Sahota A; Tischfield JA Kidney Int; 2001 Sep; 60(3):910-23. PubMed ID: 11532086 [TBL] [Abstract][Full Text] [Related]
3. Chronic renal failure in a mouse model of human adenine phosphoribosyltransferase deficiency. Stockelman MG; Lorenz JN; Smith FN; Boivin GP; Sahota A; Tischfield JA; Stambrook PJ Am J Physiol; 1998 Jul; 275(1):F154-63. PubMed ID: 9689017 [TBL] [Abstract][Full Text] [Related]
4. Family study of 2,8-dihydroxyadenine stone formation: report of two cases of a compound heterozygote for adenine phosphoribosyltransferase deficiency (APRT*J/APRT*Q0). Suzuki K; Kobayashi S; Kawamura K; Kuhara T; Tsugawa R Int J Urol; 1997 May; 4(3):304-6. PubMed ID: 9255672 [TBL] [Abstract][Full Text] [Related]
5. [2,8-dihydroxyadenine urolithiasis: case report and literature review]. Arancio M; Ranzoni S; Delsignore A; Landi G; Maffei N; Marcato M; Mina A; Martinengo C Urologia; 2011; 78(4):305-9. PubMed ID: 21553389 [TBL] [Abstract][Full Text] [Related]
6. Scanning electron microscopy of 2,8-dihydroxyadenine crystals and stones. Winter P; Hesse A; Klocke K; Schaefer RM Scanning Microsc; 1993 Sep; 7(3):1075-80. PubMed ID: 8146608 [TBL] [Abstract][Full Text] [Related]
8. Aprt/Opn double knockout mice: osteopontin is a modifier of kidney stone disease severity. Vernon HJ; Osborne C; Tzortzaki EG; Yang M; Chen J; Rittling SR; Denhardt DT; Buyske S; Bledsoe SB; Evan AP; Fairbanks L; Simmonds HA; Tischfield JA; Sahota A Kidney Int; 2005 Sep; 68(3):938-47. PubMed ID: 16105024 [TBL] [Abstract][Full Text] [Related]
9. Altered gene expression in kidneys of mice with 2,8-dihydroxyadenine nephrolithiasis. Wang L; Raikwar N; Deng L; Yang M; Liang L; Shao C; Evan AP; Stambrook PJ; Sahota A; Tischfield JA Kidney Int; 2000 Aug; 58(2):528-36. PubMed ID: 10916076 [TBL] [Abstract][Full Text] [Related]
10. [2,8-dihydroxyadenine nephrolithiasis: from diagnosis to therapy]. Bouzidi H; Lacour B; Daudon M Ann Biol Clin (Paris); 2007; 65(6):585-92. PubMed ID: 18039602 [TBL] [Abstract][Full Text] [Related]
11. [A case of adenine phosphoribosyltransferase (APRT) deficiency discovered by urine examination]. Konishi N; Takeshita K; Yasui H Nihon Jinzo Gakkai Shi; 1994 Oct; 36(10):1191-5. PubMed ID: 7815752 [TBL] [Abstract][Full Text] [Related]
12. [2,8-dihydroxyadenine urolithiasis due to partial deficiency of adenine phosphoribosyltransferase: a case report]. Ohne T; Fujito A; Koga K; Imaide Y; Uchida M Hinyokika Kiyo; 1998 Oct; 44(10):725-8. PubMed ID: 9850838 [TBL] [Abstract][Full Text] [Related]
13. Comparison of the effect of allopurinol and febuxostat on urinary 2,8-dihydroxyadenine excretion in patients with Adenine phosphoribosyltransferase deficiency (APRTd): A clinical trial. Edvardsson VO; Runolfsdottir HL; Thorsteinsdottir UA; Sch Agustsdottir IM; Oddsdottir GS; Eiriksson F; Goldfarb DS; Thorsteinsdottir M; Palsson R Eur J Intern Med; 2018 Feb; 48():75-79. PubMed ID: 29241594 [TBL] [Abstract][Full Text] [Related]
14. Urinary 2,8-dihydroxyadenine excretion in patients with adenine phosphoribosyltransferase deficiency, carriers and healthy control subjects. Runolfsdottir HL; Palsson R; Thorsteinsdottir UA; Indridason OS; Agustsdottir IMS; Oddsdottir GS; Thorsteinsdottir M; Edvardsson VO Mol Genet Metab; 2019; 128(1-2):144-150. PubMed ID: 31378568 [TBL] [Abstract][Full Text] [Related]
15. A Japanese boy with adenine phosphoribosyltransferase (APRT) deficiency caused by compound heterozygosity including a novel missense mutation in APRT gene. Nozue H; Kamoda T; Saitoh H; Ichikawa K; Taniguchi A Acta Paediatr; 2011 Dec; 100(12):e285-8. PubMed ID: 21635362 [TBL] [Abstract][Full Text] [Related]
16. Clinical, biochemical and molecular diagnosis of a compound homozygote for the 254 bp deletion-8 bp insertion of the APRT gene suffering from severe renal failure. Di Pietro V; Perruzza I; Amorini AM; Balducci A; Ceccarelli L; Lazzarino G; Barsotti P; Giardina B; Tavazzi B Clin Biochem; 2007 Jan; 40(1-2):73-80. PubMed ID: 17126311 [TBL] [Abstract][Full Text] [Related]
19. A case of a compound heterozygote for adenine phosphoribosyltransferase deficiency (APRT*J/APRT*Q0) leading to 2,8-dihydroxyadenine urolithiasis: review of the reported cases with 2,8-dihydroxyadenine stones in Japan. Takeuchi H; Kaneko Y; Fujita J; Yoshida O J Urol; 1993 Apr; 149(4):824-6. PubMed ID: 8455250 [TBL] [Abstract][Full Text] [Related]